The invention relates to the field of pharmaceutical chemistry. Specifically, the present invention relates to a series of BET (bromodomain and extra-terminal domain) inhibitors having a novel structure, particularly inhibitors targeting BRD4 (Bromodomain-containing protein 4), and a preparation method and use therefor. The structure thereof is shown in the following general formula (I). Said compounds or a stereoisomer, racemate, geometric isomer, tautomer, prodrug, hydrate, solvate, or crystal form thereof, or a pharmaceutically acceptable salt thereof, and the pharmaceutical compsosition thereof can be used for the treatment and/or prevention of related diseases mediated by bromodomain proteins.
本发明涉及药物
化学领域。具体地说,本发明涉及一系列具有新型结构的 BET(
溴基二甲基和端外域)
抑制剂,特别是针对 BR
D4(含
溴基二甲基蛋白 4)的
抑制剂,以及其制备方法和用途。其结构如下通式(I)所示。所述化合物或其立体异构体、外消旋体、几何异构体、同分异构体、原药、
水合物、溶液或晶体形式,或其药学上可接受的盐,以及其药物组合物可用于治疗和/或预防由
溴基团蛋白介导的相关疾病。